Probability underpins AI, cryptography and statistics. However, as the philosopher Bertrand Russell said, “Probability is the ...
The customary approach to early-phase clinical trial design, where the focus is on identification of the maximum tolerated dose, is not always suitable for noncytotoxic or other targeted therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results